ERBB2 and cancer: In colorectal cancer, cytoplasmic NRF2 expression has been reported to promote cancer cell invasion via regulation of PSMD4 [29], and a higher frequency of cytoplasmic NRF2 in HER-2-positive cancers and brain metastases might reflect greater invasiveness and aggressiveness.